Search Results - "Marus, Wally"
-
1
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study
Published in Breast (Edinburgh) (01-08-2024)“…Neoadjuvant chemotherapy (NACT) is widely used in the treatment of triple-negative and HER2-positive breast cancer (BC), but its use in estrogen receptor (ER)…”
Get full text
Journal Article -
2
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers
Published in Diagnostics (Basel) (01-05-2024)“…The immunohistochemical assessment of mismatch repair (MMR) proteins represents a pivotal screening tool for identifying Lynch syndrome (LS)-related cancers,…”
Get full text
Journal Article -
3
Correlation Between IgA Tissue Transglutaminase Antibody Ratio and Histological Finding in Celiac Disease
Published in Journal of pediatric gastroenterology and nutrition (01-07-2012)“…ABSTRACT Objectives: Positivity of both immumoglobulin A anti‐tissue transglutaminase (TTG) and anti‐endomysium antibodies (EMA) has a positive predictive…”
Get full text
Journal Article -
4
Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study
Published in Cytokine (Philadelphia, Pa.) (01-04-2020)“…•Feasibility, safety, activity and tolerability of IL-2 chronoinfusion in metastatic RCC.•Prognostic value of prolactin and MSKCC score on survival.•Prognostic…”
Get full text
Journal Article -
5
Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Background: Neoadjuvant chemotherapy (NACT) (+/- anti HER2) is the preferred therapy for triple negative and HER2 positive subtype breast tumors. In…”
Get full text
Journal Article -
6
Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience
Published in Cytokine (Philadelphia, Pa.) (01-01-2019)“…•Importance of immunosuppressive Treg and MDSC on tumor progression.•Immunosuppression of Treg and MDSC cells by Cyclophosphamide and Fluorouracil can improve…”
Get full text
Journal Article -
7
Neoadjuvant chemotherapy with nonpegylated liposome-encapsulated doxorubicin (NPLD) plus cyclophosphamide followed by trastuzumab plus nabpaclitaxel for HER2-positive breast cancer (BC)
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
8
Offlabel nab-paclitaxel: Gemcitabine chemotherapy in advanced pancreatic cancer—A monoinstitutional experience
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
9
Interleukin-2 (IL-2) chrono-infusion (CHI) in metastatic renal cell carcinoma (mRCC): A phase I/II study
Published in Journal of clinical oncology (10-02-2012)“…Abstract only 423 Background: The soprachiasmatic nucleus represents the pacemaker coordinating circadian rhythm. Its dysregulation in neoplastic patients…”
Get full text
Journal Article -
10
Gamma probe accuracy in detecting the sentinel lymph node in clinically N0 squamous cell carcinoma of the head and neck
Published in Annals of otology, rhinology & laryngology (01-09-2002)“…The sentinel node, which is not always located at the first-echelon nodal area close to the primary tumor, is the initial recipient of possible metastasis. In…”
Get full text
Journal Article -
11
Gamma Probe Accuracy in Detecting the Sentinel Lymph Node in Clinically No Squamous Cell Carcinoma of the Head and Neck
Published in Annals of otology, rhinology & laryngology (01-09-2002)“…The sentinel node, which is not always located at the first-echelon nodal area close to the primary tumor, is the initial recipient of possible metastasis. In…”
Get full text
Journal Article